Cargando…
Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001–2018)
BACKGROUND: The ability of Plasmodium falciparum parasites to develop resistance to widely used anti-malarials threatens malaria control and elimination efforts. Regular drug efficacy monitoring is essential for ensuring effective treatment policies. In low transmission settings where therapeutic ef...
Autores principales: | Raman, Jaishree, Kagoro, Frank M., Mabuza, Aaron, Malatje, Gillian, Reid, Anthony, Frean, John, Barnes, Karen I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704579/ https://www.ncbi.nlm.nih.gov/pubmed/31438951 http://dx.doi.org/10.1186/s12936-019-2911-y |
Ejemplares similares
-
A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa
por: Ndwiga, Leonard, et al.
Publicado: (2021) -
Continued Sensitivity of Plasmodium falciparum to Artemisinin in Guyana, With Absence of Kelch Propeller Domain Mutant Alleles
por: Rahman, Reyaud, et al.
Publicado: (2016) -
Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial
por: Raman, Jaishree, et al.
Publicado: (2019) -
Artemisinin combination therapy fails even in the absence of Plasmodium falciparum kelch13 gene polymorphism in Central India
por: Das, Sabyasachi, et al.
Publicado: (2021) -
Plasmodium falciparum artemisinin resistance monitoring in Sabah, Malaysia: in vivo therapeutic efficacy and kelch13 molecular marker surveillance
por: Grigg, Matthew J., et al.
Publicado: (2018)